MedTrace Logo

Transfusion Requirements After Head Trauma

NCT02203292 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2016-08-01

No results posted yet for this study

Summary

TRAHT is a pilot randomized clinical trial designed to evaluate safety and feasibility of two red blood cells transfusion thresholds in moderate or severe traumatic brain injured patients

Conditions

Interventions

BEHAVIORAL

Liberal transfusion strategy

Patients will have red blood cells transfused only if Hb \< 9.0 g/dL

BEHAVIORAL

Restrictive transfusion strategy

Patients will have red blood cells transfused only if Hb \< 7.0 g/dL

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • André LN Gobatto, M.D. · University of Sao Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02203292 on ClinicalTrials.gov